Dermata Therapeutics Inc. Made Big Gain
Dermata Therapeutics Inc. (DRMA:NASDAQ) jumped higher at $0.41, representing a gain of 104.5%. On Fri, Dec 30, 2022, DRMA:NASDAQ touched a New 2-Week High of $0.41. The stock got featured on our News Catalysts scanner on Mon, Dec 05, 2022 at 09:40 AM in the 'BIOTECH' category. From Fri, Dec 16, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Fri, Dec 30, 2022 at $0.54 with a volume of 45M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 104.5%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 79.37%
- SoundHound AI Inc. (SOUN:NASDAQ), 71.84%
- Palisade Bio Inc. (PALI:NASDAQ), 61.49%
- F-star Therapeutics Inc. (FSTX:NASDAQ), 54.52%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 53.58%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 47.22%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 43.38%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 40.29%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 39.26%